BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1968425)

  • 1. Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.
    Prickett TC; Hart DN
    Immunology; 1990 Feb; 69(2):250-6. PubMed ID: 1968425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells.
    Hauss P; Selz F; Cavazzana-Calvo M; Fischer A
    Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell activation by dendritic cells: CD18-dependent clustering is not sufficient for mitogenesis.
    Austyn JM; Morris PJ
    Immunology; 1988 Mar; 63(3):537-43. PubMed ID: 2832317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
    Adamthwaite D; Cooley MA
    Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V; Winkel K; Süss G; Kelso A; Heath W; Kirberg J; von Boehmer H; Shortman K
    J Immunol; 1996 Nov; 157(9):3819-27. PubMed ID: 8892611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions.
    McKenzie JL; Calder VL; Starling GC; Hart DN
    Bone Marrow Transplant; 1995 Feb; 15(2):163-71. PubMed ID: 7773205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerance by IL-10-treated dendritic cells.
    Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
    J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
    Guidos C; Sinha AA; Lee KC
    Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies.
    King PD; Katz DR
    Eur J Immunol; 1989 Apr; 19(4):581-7. PubMed ID: 2786468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human dendritic cells stimulate allogeneic T cells in the absence of IL-1.
    McKenzie JL; Prickett TC; Hart DN
    Immunology; 1989 Jul; 67(3):290-7. PubMed ID: 2527194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
    Detournay O; Mazouz N; Goldman M; Toungouz M
    Hum Immunol; 2005 May; 66(5):460-8. PubMed ID: 15935883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD; Lipsky PE
    J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both virgin and memory T cells cluster with dendritic cells during autologous and allogeneic mixed leukocyte reaction.
    Vakkila J
    Eur J Immunol; 1989 Jun; 19(6):1003-8. PubMed ID: 2526737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
    Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
    Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
    Rizzitelli A; Vremec D; Villadangos JA; Mavaddat N; Wright MD; Shortman K
    Eur J Immunol; 2005 Nov; 35(11):3209-20. PubMed ID: 16224811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.